Saving Belle & Abby from Niemann Pick Type C

9922235_1543477619771428_r.jpeg9922235_1543477639788945_r.jpeg9922235_154347767984870_r.jpeg
9922235_154347770931774_r.jpeg9922235_1543477739510358_r.jpeg9922235_154347777498729_r.jpeg

Belle & Abby Andrews
Belle & Abby Andrews are two sisters living in Austin, Texas, diagnosed with Neimann Pick Type C1 (NPC1) in March of 2016.  Belle (9yo) is big sister to Abby (5 1/2yo). 

Diagnostic Odyssey
In 2014, parents Pam and Chris Andrews noticed their oldest daughter, Belle, was showing some developmental delays in her gross and fine motor skills. Because she was only 3 years old, the delays were subtle and it was hard to know what was normal development and what was cause for concern. But Pam and Chris sensed that something was wrong with their daughter. They sought answers from a multitude of specialists, including speech therapists, vision therapists, physical therapists, neurologists, oncologists, ENTs, nephrologists, endocrinologists, among others. Their search culminated with Drs. Amy White and Mary Elizabeth Parker, who advised them to have Belle’s genome analyzed by Whole Exome Sequencing in order look for potential genetic diseases.

The family was crushed when the test results revealed that then almost 6 year-old Belle had Niemann-Pick Disease Type C1, a genetic disease so rare that Pam and Chris had never even heard of it. There are only 2000 diagnosed cases of NPC1 in the world and only 100 in the US.

Shortly after receiving Belle’s results, their geneticist Dr. James Gibson suggested that the Andrews have their two-year-old daughter, Abby, tested. They were devastated again when Dr. Gibson confirmed that Abby also had NPC1.

The Disease
NPC1 is a progressive, neurodegenerative disease where the lysosomes of all cells of the body accumulate toxic amounts of lipids, causing progressive damage to the brain, spleen, liver, and other tissues. If left untreated, Belle and Abby will likely eventually suffer from seizures, dementia, ataxia, and cataplexy. As the disease progresses, children diagnosed with NPC1 require feeding tubes because of difficulty swallowing, are confined to wheelchairs, are unable to speak or recognize loved ones, and die in adolescence.

Finding hope and living with determination
After pouring over the research and talking with other NPC1 families, the Andrews family found a bit of solace in a growing community of fellow NPC1 families who were able to share their journey. They also learned of a clinical trial being conducted by Vtesse, a rare disease pharmaceutical company, and the National Institute of Health (NIH), to evaluate a drug called VTS-270 for its effectiveness in treating NPC1. There is currently no FDA-approved drug to slow the progression of NPC1.

Through tireless efforts by Pam and Chris, Belle was admitted into the clinical trial and Abby was granted compassionate use of the drug. This meant the family traveled to Chicago every two weeks so the girls could receive treatment, which has taken an emotional, physical and financial toll on the entire family.

Because the Andrews live in Austin, they reached out to everyone they knew who might have connections with Seton Family Healthcare, a part of Assencion Healthcare and Dell Children’s Medical Center (DCMC), a research hospital in Austin they felt would be a prime candidate for helping to administer VTS-270 for the Vtesse trial. Through their vigilant efforts, DCMC heeded the call of these vulnerable children faster than any other hospital participating in this clinical trial in the world, and implemented a VTS-270 trial for all affected children in their region.

In January 2017, just eight months after their initial diagnoses, Belle and Abby began receiving treatments of VTS-270 at DCMC, just a twenty minute drive from home.

In the meantime, the Andrews family continues to hope this clinical trial results in the FDA approval of VTS-270, so their daughters and other afflicted children can begin to get some relief from this insidious disease.

We want to save our daughters and we need your help to do so. 
NPC1 is an ultra-rare genetic disease and the expense of caring for two children with such a rare disease have proven to be something unimaginable.  

While Belle and Abby receive treatments of VTS-270 at Dell Children's in Austin now, the family still has considerable medical and travel expenses – up to six different therapies a week for Belle, including a full-time shadow at her school, as well as making trips to Chicago for assessments and to the NIH for additional assessments.  

While Pam and Chris both continue to work full time, the Andrews family is humbly asking for help.  They need any kind of support you can offer.  This effort will take a village and they will not be able to do this alone. Pam and Chris are desperate to help save their daughters from this cruel and hideous disease.  They are equally determined to help find a cure for this disease and are working tirelessly to help raise awareness and find a cure for this disease.  

Thank you in advance for your kindness, your love, your prayers, and your generosity.

Donations

  • Anonymous 
    • $250 
    • 4 mos
  • curtis fuelberg 
    • $50 
    • 4 mos
  • Karina Davis 
    • $100 
    • 4 mos
  • Anonymous 
    • $100 
    • 5 mos
  • Anonymous 
    • $500 
    • 5 mos
See all

Organizer

Pam Crowley Andrews 
Organizer
Austin, TX
  • #1 fundraising platform

    People have raised more money on GoFundMe than anywhere else. Learn more

  • GoFundMe Guarantee

    In the rare case that something isn’t right, we will refund your donation. Learn more

  • Expert advice, 24/7

    Contact us with your questions and we’ll answer, day or night. Learn more